Insider trade

Director sold ~$212K of AGX shares in the open market

Traded Jun 17, 2026 · Filed Jun 17, 2026

Why it stands out

A board member of Argan sold $212K of Argan shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$211,500

Shares × reported transaction price

Timing vs results

13 days after results of Jun 4, 2026, 77 days before results of Sep 2, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.9%	−1.7%	+3.6%
30 days	−18.5%	−0.6%	−17.9%
90 days	−46.7%	+1.0%	−47.7%

Past results only. Not a forecast.

On June 17, 2026, the Reporting Person sold 300 shares of the Issuer's common stock on the open market at a price of $705 per share.

3mo ago

Derivative exercise or conversion — not an open-market buy.

3mo ago

Derivative exercise or conversion — not an open-market buy.

3mo ago

Derivative exercise or conversion — not an open-market buy.